There are studies that established the association of CREB activity as an essential driver of tumor aggressiveness; however, there is a lack of molecular and cellular evidence exploring the regulation and activation of CREB as well as its role in influencing the EMP transcriptional program, warranting future investigations of these mechanisms in PDAC. The gene discussed is MAEA; the disease is neoplasm.